Article
Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate.
The Journal of infectious diseases - 1 Apr 2000
Oram R J, Marcellino D, Strauss D, Gustafson E, Talarico C L, Root A K, Sharma P L, Thompson K, Fingeroth J D, Crumpacker C, Herold B C
Abstract excerpt
Acyclovir resistance is not a recognized problem among neonates with perinatal herpes simplex virus (HSV) infection. A premature newborn with neurocutaneous HSV infection was treated for 21 days with acyclovir. Disseminated disease recurred 8 days later. A recurrent isolate was resistant to acyclovir and lacked thymidine kinase activity on the basis of a frameshift mutation in the thymidine kinase (tk) gene....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
